Palisade Bio (PALI) Shares Outstanding (Weighted Average) (2010 - 2026)
Palisade Bio (PALI) reported Shares Outstanding (Weighted Average) of $209.7 million for Q1 2026, up 4271.97% year-over-year from $4.8 million in Q1 2025, and up 227.44% on a QoQ basis from $64.0 million in Q4 2025.
Palisade Bio (PALI) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $209.7 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 4271.97% year-over-year to $209.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $209.7 million (up 4271.97% YoY) and the FY2025 annual result came in at $64.0 million, up 4420.47% from the prior year.
- Shares Outstanding (Weighted Average) grew to $209.7 million in Q1 2026 per PALI's latest filing, from $64.0 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $209.7 million in Q1 2026 and bottomed at $287702.0 in Q1 2023.
- The 5-year median for Shares Outstanding (Weighted Average) is $880311.0 (2022), against an average of $17.5 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) tumbled 93.01%; it then surged 4420.47% in 2025.
- Tracing PALI's Shares Outstanding (Weighted Average) over 5 years: stood at $880311.0 in 2022, then sank by 48.2% to $456014.0 in 2023, then jumped by 210.62% to $1.4 million in 2024, then surged by 4420.47% to $64.0 million in 2025, then surged by 227.44% to $209.7 million in 2026.
- Per Business Quant, the three latest PALI Shares Outstanding (Weighted Average) figures stand at $209.7 million (Q1 2026), $64.0 million (Q4 2025), and $5.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 209.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209.66 Mn |
| Dec 31, 2025 | 64.03 Mn |
| Sep 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 768,137.00 |
| Dec 31, 2023 | 456,014.00 |
| Sep 30, 2023 | 402,074.00 |
| Jun 30, 2023 | 427,862.00 |
| Mar 31, 2023 | 287,702.00 |
| Dec 31, 2022 | 880,311.00 |
| Sep 30, 2022 | 572,684.00 |
| Jun 30, 2022 | 405,893.00 |
| Mar 31, 2022 | 324,473.00 |
| Dec 31, 2021 | 186,195.00 |
| Sep 30, 2021 | 7.90 Mn |
| Jun 30, 2021 | 5.80 Mn |
| Mar 31, 2021 | 2.77 Mn |
| Dec 31, 2020 | 2.77 Mn |
| Sep 30, 2020 | 2.77 Mn |
| Jun 30, 2020 | 10.39 Mn |
| Mar 31, 2020 | 1.36 Mn |
| Dec 31, 2019 | 2.20 Mn |
| Sep 30, 2019 | 149,136.00 |
| Jun 30, 2019 | 149,136.00 |
| Mar 31, 2019 | 910,821.00 |
| Dec 31, 2018 | 653,221.00 |
| Sep 30, 2018 | 2.98 Mn |
| Jun 30, 2018 | 2.98 Mn |
| Mar 31, 2018 | 15.12 Mn |
| Dec 31, 2017 | 13.06 Mn |
| Sep 30, 2017 | 12.38 Mn |
| Jun 30, 2017 | 11.91 Mn |
| Mar 31, 2017 | 11.14 Mn |
| Dec 31, 2016 | 8.35 Mn |
| Sep 30, 2016 | 8.02 Mn |
| Jun 30, 2016 | 8.14 Mn |
| Mar 31, 2016 | 7.08 Mn |
| Dec 31, 2015 | 6.99 Mn |
| Sep 30, 2015 | 90.53 Mn |
| Jun 30, 2015 | 90.00 Mn |
| Mar 31, 2015 | 89.65 Mn |
| Dec 31, 2014 | 87.09 Mn |
| Sep 30, 2014 | 87.37 Mn |
| Jun 30, 2014 | 86.48 Mn |
| Mar 31, 2014 | 85.75 Mn |
| Dec 31, 2013 | 72.28 Mn |
| Sep 30, 2013 | 72.99 Mn |
| Jun 30, 2013 | 69.59 Mn |
| Mar 31, 2013 | 68.70 Mn |
| Dec 31, 2012 | 58.15 Mn |
| Sep 30, 2012 | 54.75 Mn |
| Jun 30, 2012 | 52.76 Mn |
| Mar 31, 2012 | 51.43 Mn |
| Dec 31, 2011 | 48.34 Mn |
| Sep 30, 2011 | 48.23 Mn |
| Jun 30, 2011 | 48.49 Mn |
| Mar 31, 2011 | 47.69 Mn |
| Dec 31, 2010 | 43.47 Mn |
| Sep 30, 2010 | 46.16 Mn |
| Jun 30, 2010 | 42.45 Mn |